Cell Proteomic Footprinting: Advances in the Quality of Cellular and Cell-Derived Cancer Vaccines
In omics sciences, many compounds are measured simultaneously in a sample in a single run. Such analytical performance opens up prospects for improving cellular cancer vaccines and other cell-based immunotherapeutics. This article provides an overview of proteomics technology, known as cell proteomi...
Main Authors: | Petr G. Lokhov, Elena E. Balashova, Oxana P. Trifonova, Dmitry L. Maslov, Alexander I. Archakov |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/15/2/661 |
Similar Items
-
Antigenic Essence: Upgrade of Cellular Cancer Vaccines
by: Petr G. Lokhov, et al.
Published: (2021-02-01) -
Changing Landscape of Cancer Vaccines—Novel Proteomics Platform for New Antigen Compositions
by: Petr G. Lokhov, et al.
Published: (2022-04-01) -
SANTAVAC<sup>TM</sup>: Summary of Research and Development
by: Petr G. Lokhov, et al.
Published: (2019-11-01) -
From genomes to vaccines via the proteome
by: R Alan Wilson, et al.
Published: (2004-08-01) -
Proteomics, Bioinformatics and Structure-Function Antigen Mining For Gonorrhea Vaccines
by: Benjamin I. Baarda, et al.
Published: (2018-12-01)